Peer AI, a leading agentic AI platform for life sciences regulatory documentation, announced the appointment of David Florez as vice president of sales. In this role, Florez will lead go-to-market strategy, drive adoption of AI-powered regulatory intelligence, and build deeper customer relationships to support successful change management as organizations modernize document-intensive regulatory workflows.

The appointment comes at a pivotal moment for the life sciences industry. Companies are moving rapidly from AI pilot programs to scaled production deployments across regulated workflows. Research and development teams are increasingly adopting purpose-built AI solutions that deliver measurable outcomes in mission-critical processes.

Supporting the Shift from AI Pilots to Production

As regulatory writing demands increase and deployment complexity grows in highly regulated environments, Peer AI continues to invest in leadership and expertise to help customers navigate this transformation.

“AI implementation requires world-class technology alongside governance, validation, change management, and organizational alignment,” said Anita Modi, CEO and co-founder of Peer AI. “David brings deep life sciences experience and proven go-to-market success helping customers manage change during major technology transitions. His leadership will be instrumental as we enter our next phase of growth.”

Proven Experience in Regulated Enterprise Environments

Florez previously spent six years at Veeva Systems in senior sales roles, partnering with pharmaceutical and biotechnology organizations to deploy cloud solutions across clinical, regulatory, and quality domains.

His experience scaling adoption of mission-critical platforms in highly regulated industries positions him to accelerate Peer AI’s market expansion and customer success initiatives.

“Regulatory documentation continues to be a major bottleneck in drug development,” said Florez. “Even with strong content and data management systems, the process slows innovation. This is an area ready for change, and Peer AI is leading that shift. I’m excited to help organizations realize the value of agentic AI and redefine how this work gets done.”

Purpose-Built AI for Regulatory Workflows

The Peer AI platform combines domain-specific AI agents with an intuitive, AI-powered interface that enables medical writers to apply their subject matter expertise at key control points throughout regulatory documentation workflows.

Leading pharmaceutical companies and emerging biotechnology firms are already saving thousands of hours while improving the quality of regulatory documents across pre-clinical development, clinical trials, regulatory affairs, and chemistry, manufacturing, and controls (CMC).